Analyses & Displays for Hepatotoxicity

Project Scope

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.

Project Leads	Email
Melvin Munsaka, AbbVie	melvin.munsaka@abbvie.com
Terry Walsh, Astellas	terry.walsh@astellas.com
Nicola Newton, PHUSE Project Assistant	nicky@phuse.global

CURRENT STATUS Q4 2024
Finalise Stage 1 white paper following public review. Get Stage 2 white paper ready for public review.

Objectives & Deliverables	Timelines
Finalise Stage 1 of draft White Paper	Q4 2023

WORKING GROUPS

Analyses & Displays for Hepatotoxicity

Related content